AiPharma forms alliance with Appili Therapeutics

5th October 2021 Uncategorised 0

Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Therapeutics Inc (Appili), to advance the global development of Avigan®/Reeqonus™ (favipiravir).

More: AiPharma forms alliance with Appili Therapeutics
Source: News